News & Media
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva pharmaceuticals Stock Photo - Alamy
Teva 'optimistic' opioid settlement could come within year following historic $26B deal with Johnson & Johnson, 3 distributors | Fierce Pharma
Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
Teva CEO stands down during troubled times - MedCity News
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Teva Unveils New Spring 2022 Collection
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Unveils New Spring 2022 Collection
Bristol Myers Squibb's Revlimid finally faces competition in the U.S. with Teva's generic launch | Fierce Pharma
Teva settles with Rhode Island on opioid-related claims
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
N.Y. jury holds drugmaker Teva liable in opioid crisis | The Sumter Item
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Price, Quote & News | Stock Analysis
New York jury holds drug firm Teva liable in opioid crisis
Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in
Top Factors Driving the Injectable Drug Delivery Formulation Market| A comprehensive study on Key Players- Gerresheimer, Pfizer, Teva Pharmaceutical Industries « MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets | News Direct
News & Media
Teva: A Complete Overview (NYSE:TEVA) | Seeking Alpha
$225 Million Settlement Reached With Teva Pharmaceutical Industries Is Fourth Opioid Settlement For Texas - Ksst Radio
